approval
saveBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
December 22, 2025updated 5mo ago
community read0 votes
Sponsor: LGM PHARMA. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approvalDec 22, 2025
- approvalBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE: BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approvalDec 22, 2025
- approvalLEVORPHANOL TARTRATE: LEVORPHANOL TARTRATE — FDA approvalDec 22, 2025
- approvalHYDROXYZINE HYDROCHLORIDE: HYDROXYZINE HYDROCHLORIDE — FDA approvalDec 16, 2025
- approvalomeprazole DR: OMEPRAZOLE AND SODIUM BICARBONATE (OMEPRAZOLE) — FDA approvalDec 10, 2025
- approvalSERTRALINE HYDROCHLORIDE: SERTRALINE HYDROCHLORIDE — FDA approvalJan 20, 2026
🐶 often sniffed alongside
top 8- tagApproval58 co-mentions · 29 sources
- drugBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE33 co-mentions · 11 sources
- tagSmall Molecule29 co-mentions · 29 sources
- drugStem Cell Therapy for Coronavirus Disease 2019 (COVID-19)22 co-mentions · 11 sources
- drugaspirin22 co-mentions · 11 sources
- drugSYNALGOS-DC22 co-mentions · 11 sources
- drugcodeine11 co-mentions · 11 sources
- drugcaffeine11 co-mentions · 11 sources
comments(0)
5-min edit window · permanent after that